The European Association of Urology (EAU) recommends utilizing magnetic resonance imaging (MRI) in cases of suspected PCa marked by elevated levels of prostate-specific antigen (PSA) or suspicious findings on digital rectal examination (DRE). The gene discussed is KLK3; the disease is posterior cortical atrophy.